CI
ALXN
CX Institutional’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-452
| Closed | -$83K | – | 989 |
|
|
2021
Q2 | $83K | Buy |
452
+140
| +45% | +$25.7K | 0.01% | 469 |
|
|
2021
Q1 | $48K | Buy |
312
+48
| +18% | +$7.39K | ﹤0.01% | 502 |
|
|
2020
Q4 | $41K | Buy |
264
+78
| +42% | +$12.1K | ﹤0.01% | 478 |
|
|
2020
Q3 | $21K | Buy |
186
+55
| +42% | +$6.21K | ﹤0.01% | 538 |
|
|
2020
Q2 | $15K | Buy |
131
+71
| +118% | +$8.13K | ﹤0.01% | 508 |
|
|
2020
Q1 | $5K | Sell |
60
-21
| -26% | -$1.75K | ﹤0.01% | 564 |
|
|
2019
Q4 | $9K | Buy |
81
+53
| +189% | +$5.89K | ﹤0.01% | 450 |
|
|
2019
Q3 | $3K | Sell |
28
-30
| -52% | -$3.21K | ﹤0.01% | 707 |
|
|
2019
Q2 | $8K | Sell |
58
-50
| -46% | -$6.9K | ﹤0.01% | 539 |
|
|
2019
Q1 | $15K | Buy |
+108
| New | +$15K | ﹤0.01% | 423 |
|